Elevated C-Reactive Protein Levels in Patients with Polypoidal Choroidal Vasculopathy and Patients with Neovascular Age-Related Macular Degeneration

Ophthalmology

Volumn 114, Issue 9, 2007, Pages 1722-1727

  Kikuchi, Masato ^a   Nakamura, Makoto ^a   Ishikawa, Kohei ^a   Suzuki, Toshimitsu ^a   Nishihara, Hiroaki ^a   Yamakoshi, Tomomi ^a   Nishio, Kazuko ^a   Taki, Kentaro ^a   Niwa, Toshimitsu ^a   Hamajima, Nobuyuki ^a   Terasaki, Hiroko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOROID DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; JAPANESE; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHOROID; CHOROID DISEASES; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; CONFIDENCE INTERVALS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; LATEX FIXATION TESTS; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; QUESTIONNAIRES;

EID: 34548272135     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.12.021     Document Type: Article

References (44)

1. Yannuzzi L.A., Sorenson J., Spaide R.F., and Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10 (1990) 1-8
2. Yannuzzi L.A., Wong D.W., Sforzolini B.S., et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 117 (1999) 1503-1510
3. Ciardella A.P., Donsoff I.M., Huang S.J., et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol 49 (2004) 25-37
4. Spaide R.F., Yannuzzi L.A., Slakter J.S., et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15 (1995) 100-110
5. Iida T., Yannuzzi L.A., Freund K.B., et al. Retinal angiopathy and polypoidal choroidal vasculopathy. Retina 22 (2002) 455-463
6. Imaizumi H., and Takeda M. Knobby-like choroidal neovascularization accompanied with retinal pigment epithelial detachment. [in Japanese]. Nippon Ganka Gakkai Zasshi 103 (1999) 527-537
7. Lafaut B.A., Aisenbrey S., Van den Broecke C., et al. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 20 (2000) 650-654
8. Terasaki H., Miyake Y., Suzuki T., et al. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol 86 (2002) 321-327
9. Okubo A., Sameshima M., Uemura A., et al. Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 86 (2002) 1093-1098
10. Yuzawa M., Mori R., and Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 89 (2005) 602-607
11. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
12. Ambati J., Ambati B.K., Yoo S.H., et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48 (2003) 257-293
13. Penfold P.L., Madigan M.C., Gillies M.C., and Provis J.M. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 20 (2001) 385-414
14. Hageman G.S., Luthert P.J., Victor Chong N.H., et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20 (2001) 705-732
15. Anderson D.H., Mullins R.F., Hageman G.S., and Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134 (2002) 411-431
16. Penfold P.L., Killingsworth M.C., and Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 223 (1985) 69-76
17. van der Schaft T.L., Mooy C.M., de Bruijn W.C., and de Jong P.T. Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol 77 (1993) 657-661
18. Seddon J.M., Gensler G., Milton R.C., et al. Association between C-reactive protein and age-related macular degeneration. JAMA 291 (2004) 704-710
19. Seddon J.M., George S., Rosner B., and Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123 (2005) 774-782
20. Vine A.K., Stader J., Branham K., et al. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 112 (2005) 2076-2080
21. Dasch B., Fuhs A., Behrens T., et al. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol 123 (2005) 1501-1506
22. Seddon J.M., Gensler G., Klein M.L., and Milton R.C. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition 22 (2006) 441-443
23. Seddon J.M., Gensler G., Klein M.L., and Milton R.C. Evaluation of plasma homocysteine and risk of age-related macular degeneration. Am J Ophthalmol 141 (2006) 201-203
24. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
25. Koenig W., Sund M., Frohlich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
26. Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
27. Klein R., Klein B.E., Knudtson M.D., et al. Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol 140 (2005) 35-44
28. McGwin G., Hall T.A., Xie A., and Owsley C. The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br J Ophthalmol 89 (2005) 1166-1170
29. Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. [in Japanese]. Nippon Ganka Gakkai Zasshi 109 (2005) 417-427
30. van Leeuwen R., Klaver C.C., Vingerling J.R., et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study. Arch Ophthalmol 121 (2003) 519-526
31. Nishio K., Tanaka D., Atsuta Y., et al. Genotype announcement in a genetic polymorphism study for health checkup examinees at Nagoya University Hospital. Nagoya J Med Sci 67 (2004) 45-49
32. Oshima Y., Ishibashi T., Murata T., et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 85 (2001) 1153-1157
33. Miyazaki M., Nakamura H., Kubo M., et al. Risk factors for age related maculopathy in a Japanese population: the Hisayama study. Br J Ophthalmol 87 (2003) 469-472
34. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
35. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102 (2005) 7227-7232
36. Gold B., Merriam J.E., Zernant J., et al., AMD Genetics Clinical Study Group. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38 (2006) 458-462
37. Rodrigues de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41 (2004) 355-367
38. Mold C., Kingzette M., and Gewurz H. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. J Immunol 133 (1984) 882-885
39. Johnson P.T., Betts K.E., Radeke M.J., et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A 103 (2006) 17456-17461
40. MacCumber M.W., Dastgheib K., Bressler N.M., et al. Clinicopathologic correlation of the multiple recurrent serosanguineous retinal pigment epithelial detachments syndrome. Retina 14 (1994) 143-152
41. Yannuzzi L.A., Ciardella A., Spaide R.F., et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115 (1997) 478-485
42. Yamada S., Gotoh T., Nakashima Y., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 153 (2001) 1183-1190
43. Vingerling J.R., Dielemans I., Hofman A., et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102 (1995) 205-210
44. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460